Medicus Pharma to acquire Antev for $75M in share exchange transaction

Stock Information for Medicus Pharma Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Medicus Pharma Ltd.

Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer
Medicus Pharma Ltd. to Present at 2025 Bio International Convention
Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses
Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering
Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari
Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering
Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.